New Oral Anticoagulants and the Cancer Patient

  • Short N
  • Connors J
194Citations
Citations of this article
214Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Cite the current indications, basic clinical pharmacology, and rationale for development of the new oral anticoagulants. Explain the potential risk for drug-drug interactions between the new oral anticoagulants and drugs commonly used in cancer patients.

Cite

CITATION STYLE

APA

Short, N. J., & Connors, J. M. (2014). New Oral Anticoagulants and the Cancer Patient. The Oncologist, 19(1), 82–93. https://doi.org/10.1634/theoncologist.2013-0239

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free